期刊文献+

RNA干扰抑制KATO-Ⅲ CD133阳性胃癌细胞CD133基因表达及对其生物学特性的影响 被引量:7

Effect of RNA interference inhibition to expression of CD133 on tumor cell biological characteristics in KATO-Ⅲ CD133+ cells of human gastric cancer
原文传递
导出
摘要 目的 探讨CD133基因表达被抑制后对胃癌细胞增殖、侵袭、克隆球形成及化疗药物敏感性的影响.方法 通过免疫磁珠分选KATO-Ⅲ胃癌细胞中的CD133阳性细胞,将合成的CD133小干扰核糖核酸分子(siRNA)转染至KATO-ⅢCD133阳性胃癌细胞内,使用荧光标记的siRNA (FAM-siRNA)检测转染效率,通过RT-PCR、Western-blot方法检测CD133基因表达的沉默效果及上皮-间质转化(EMT)相关因子(E-cadherin、Snail和N-cadherin)的蛋白表达,采用CCK-8、Transwell侵袭实验、单克隆球形成实验和CCK- 8等方法分别检测细胞增殖、侵袭、克隆球形成能力及对化疗药物5-氟尿嘧啶(5-FU)的敏感性.结果 转染24 h后,转染效率可达到(87.7±8.1)%.干扰组CD133 mRNA及蛋白的表达显著低于阴性对照组(P<0.01).转染24、48和72 h后,与阴性对照组比较,干扰组细胞的增殖活性均得到显著抑制,差异均有统计学意义(P<0.01);转染72 h,干扰组细胞的增殖活性较阴性对照组降低了(52.1±8.0)%.与阴性对照组比较,干扰组的细胞侵袭数减少[(41.7±6.0)比 (130.3±11.0),P<0.05],克隆球形成率降低[(24.3±4.3)%比(45.1±6.4)%,P<0.01],Snail和N- cadherin蛋白表达降低(P<0.01),而E-cadherin蛋白表达增高(P<0.01).干扰组细胞对化疗药物5-FU的敏感性显著增强,5-FU对干扰组细胞的抑制率为(62.4±3.3)%,较阴性对照组的(21.5±2.2)%增加(P<0.01).结论 CD133基因在胃癌细胞的增殖、侵袭、克隆球形成和化疗抵抗性等方面具有重要作用,可能是胃癌干细胞新型标志物,有望成为胃癌生物治疗的新靶点. Objective To investigate the changes in proliferation,invasiveness,clone sphere formation and chemosensitivity of human gastric cancer cell lines of KATO-Ⅲ CD133+ cells transfected with small interfering RNA (siRNA) against CD133 gene.Methods CD133+ cells of KATO-Ⅲ cell lines were isolated by magnetic activated cell sorting (MACS).CD133 siRNA was designed and synthesized,and then transfected into KATO-Ⅲ CD133 + cells.Cell fluorescence counting under confocal laser scanning microscope was used to determine the transfection efficiency after transfection with the CD133 FITC-siRNA.The knock-down effect of the CD133 gene and expression of epithelialmesenchymal transition (EMT)-related factors were detected by RT-PCR and Western blotting.Cell counting kit-8 assay (CCK-8),transwell chamber and colony sphere forming assay were performed to measure the variation of cell proliferative,invasive,colony formation viability and chemosensitivity to 5FU after the above-mentioned treatment.Results The transfection efficiency was (87.7±8.1)%.The CD133 mRNA and protein expression levels in the interference group were lower than those in negative control group.Twenty-four,48 and 72 hours after transfection,cells proliferation activity was significantly inhibited in the interference group compared with negative control group,(all P〈0.01).Seventy-two hours after transfection,compared with negative control group,cells proliferation activity was reduced by (52.1±8.0)%.The invasive cell number reduced(41.7±6.0 vs.130.3±11.0,P〈0.05) and clone formation rate decreased significantly[(24.3±4.3)% vs.(45.1±6.4)%,P〈0.01] in the interference group.EMT-related gene E-cadherin protein expression increased,while the Snail and N-cadherin protein expression reduced in the interference group (all P〈0.01).The cells sensitivity to 5-FU was significantly enhanced in the interference group,and the cell inhibition rate of 5-Fu was (62.4±3.3)%,higher than that in negative control group [(21.5±2.2)%,P〈0.01].Conclusions The expression of CD133 gene plays an important role in cell proliferation,invasiveness,colony formation and resistance to chemotherapy of KATO-Ⅲ CD133+ gastric cancer cells.It suggests that CD133 can be used as one of surface markers for detection of gastric cancer stem cells.Inhibination of CD133 expression may be a promising way for gastric cancer biotherapy.
出处 《中华胃肠外科杂志》 CAS CSCD 2013年第9期889-894,共6页 Chinese Journal of Gastrointestinal Surgery
基金 国家自然科学基金(81101850) 上海市卫生局重点基金(2010018) 上海市教委基金(jdy10022) 上海交通大学医学院科研基金(YZ1055)
关键词 胃肿瘤 干细胞 RNAI CD133 Stomach neoplasms Cancer stem cell RNAi CD133
  • 相关文献

参考文献4

二级参考文献67

  • 1Hambardzumyan D,Squartro M,Holland EC.Radiation resistance and stem-like cells in brain tumors[J].中国神经肿瘤杂志,2006,4(4). 被引量:34
  • 2Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nat Med,1997,3(7):730-737.
  • 3Wulf GG,Wang RY,Kuehnle 1,et al.A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia[J].Blood,2001,98(4):1166-1173.
  • 4Pérez Castillo A,Aguilar-Morante D,Morales-García JA,et al.Cancer stem cells and brain tumors[J].Clin Transl Oncol,2008,10(5):262-267.
  • 5Field M,Alvarez A,Bushnev S,et al.Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients[J].Clin Neurosurg,2010,57:151-159.
  • 6Yu SC,Ping YF,Yi L,et al.Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87[J].Cancer Lett,2008,265(1):124-134.
  • 7Miraglia S,Godfrey W,Yin AH,et al.A novel five-transmembrane hematopoietic stem cell antigen:isolation,characterization,and molecular cloning[J].Blood,1997,90(12):5013-5021.
  • 8Kang MK,Kang SK.Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma[J].Stem Cells Dev,2007,16(5):837-847.
  • 9O'Brien CA,Pollett A,Gallinger S,et al.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J].Nature,2007,445(7123):106-110.
  • 10Rappa G,Fodstad O,Lorico A.The stem cell-associated antigen CD133 (prominin-1) is a molecular therapeutic target for metastatic melanoma[J].Stem Cells,2008,26 (12):3008-3017.

共引文献98

同被引文献116

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部